The C6‐2B glioma cell P2YAC receptor is pharmacologically and molecularly identical to the platelet P2Y12 receptor
- 1 June 2001
- journal article
- Published by Wiley in British Journal of Pharmacology
- Vol. 133 (4), 521-528
- https://doi.org/10.1038/sj.bjp.0704114
Abstract
P2Y receptor activation in many cell types leads to phospholipase C activation and accumulation of inositol phosphates, while in blood platelets, C6-2B glioma cells, and in B10 microvascular endothelial cells a P2Y receptor subtype, which couples to inhibition of adenylyl cyclase, historically termed P2Y(AC), (P2T(AC) or P(2T) in platelets) has been identified. Recently, this receptor has been cloned and designated P2Y(12) in keeping with current P2 receptor nomenclature. Three selective P(2T) receptor antagonists, with a range of affinities, inhibited ADP-induced aggregation of washed human or rat platelets, in a concentration-dependent manner, with a rank order of antagonist potency (pIC(50), human: rat) of AR-C78511 (8.5 : 9.1)>AR-C69581 (6.2 : 6.0)>AR-C70300 (5.4 : 5.1). However, these compounds had no effect on ADP-induced platelet shape change. All three antagonists had no significant effect on the ADP-induced inositol phosphate formation in 1321N1 astrocytoma cells stably expressing the P2Y(1) receptor, when used at concentrations that inhibit platelet aggregation. These antagonists also blocked ADP-induced inhibition of adenylyl cyclase in rat platelets and C6-2B cells with identical rank orders of potency and overlapping concentration - response curves. RT - PCR and nucleotide sequence analyses revealed that the C6-2B cells express the P2Y(12) mRNA. These data demonstrate that the P2Y(AC) receptor in C6-2B cells is pharmacologically identical to the P2T(AC) receptor in rat platelets.Keywords
This publication has 37 references indexed in Scilit:
- ADP Is the Cognate Ligand for the Orphan G Protein-coupled Receptor SP1999Journal of Biological Chemistry, 2001
- Defective platelet aggregation and increased resistance to thrombosis in purinergic P2Y1 receptor–null miceJCI Insight, 1999
- Ligand specificity and ticlopidine effects distinguish three human platelet ADP receptorsEuropean Journal of Pharmacology, 1998
- P2Y1‐receptors in human platelets which are pharmacologically distinct from P2YADP‐receptorsBritish Journal of Pharmacology, 1998
- Fidelity in functional coupling of the rat P2Y1 receptor to phospholipase CBritish Journal of Pharmacology, 1997
- Functional Characterization of the Ocular Prostaglandin F2α (PGF2α) ReceptorPublished by Elsevier ,1997
- Molecular Cloning of a Novel P2 Purinoceptor from Human Erythroleukemia CellsPublished by Elsevier ,1996
- Cloning and Chromosomal Localization of the Human P2Y1 PurinoceptorBiochemical and Biophysical Research Communications, 1996
- A novel series of P2T purinoceptor antagonists: definition of the role of ADP in arterial thrombosisTrends in Pharmacological Sciences, 1995
- ADP and, indirectly, ATP are potent inhibitors of cAMP production in intact isoproterenol-stimulated C6 glioma cellsBiochemical and Biophysical Research Communications, 1989